Objective To understand the risk of invasive fungal infection at phase of preengraft- ment of allogeneic hematopoietic stem cell transplantation(HSCT).
目的提高对异基因造血干细胞移植后早期深部真菌感染风险的认识。
Early diagnosis and rational treatment, allogeneic hematopoietic stem cell transplantation in particular, are the key to the prolongation of survival time of children with erythroleukemia.
尽早诊断、合理治疗；异基因外周血造血干细胞移植是提高该病患儿生存期的关键。
The aim of this study was to analyze the hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT).
本研究旨在探讨非清髓异基因外周血造血干细胞移植(NAPBSCT)后造血嵌合体的临床意义。
The aim of this study was to analyze the hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT).
本研究旨在探讨非清髓异基因外周血造血干细胞移植(NAPBSCT)后造血嵌合体的临床意义。
应用推荐